Laserscope (MM) News - LSCP

Laserscope Reports 2005 Fourth Quarter and Year-End Operating Results

Fourth Quarter Results Driven by Record Worldwide GreenLight(TM) Product Revenues, Strong Aesthetic Sales and Significant Increases in R&D...

Laserscope Schedules 2005 Fourth Quarter and Year-End Conference Call

SAN JOSE, Calif., Feb. 15 /PRNewswire-FirstCall/ -- Laserscope (NASDAQ:LSCP), a pioneer in the development and commercialization of...

Laserscope Announces Issuance of U.S. Patent

Laser Vaporization Patent Strengthens the Company's Photoselective Vaporization Patent Portfolio SAN JOSE, Calif., Jan. 26...

European Study Highlights Laserscope's Greenlight PV(R) System Effective in Relieving BPH Symptoms With Improved Safety and Lowe

SAN JOSE, Calif., Jan. 10 /PRNewswire-FirstCall/ -- Laserscope (NASDAQ:LSCP), a pioneer in the development and commercialization of...

Laserscope Provides Details About New CMS Reimbursement for In-Office PVP Procedure

SAN JOSE, Calif., Jan. 5 /PRNewswire-FirstCall/ -- Laserscope (NASDAQ:LSCP), a pioneer in the development and commercialization of...

Laserscope Announces Intended Resignation of Board Member

SAN JOSE, Calif., Dec. 15 /PRNewswire-FirstCall/ -- Laserscope (NASDAQ:LSCP), a pioneer in the development and commercialization of...

Laserscope to Present at Harris Nesbitt Focus on Healthcare Conference

SAN JOSE, Calif., Dec. 6 /PRNewswire-FirstCall/ -- Laserscope (NASDAQ:LSCP), a pioneer in the development and commercialization of...

Laserscope to Present at Lazard Capital Markets Life Sciences Conference

SAN JOSE, Calif., Nov. 29 /PRNewswire-FirstCall/ Laserscope (NASDAQ:LSCP), a pioneer in the development and commercialization of...

Laserscope Reports 2005 Third Quarter Operating Results, Updates Guidance for 2005 and Sets Initial Guidance for 2006

Solid Year-Over-Year Revenue Growth Driven by Domestic and International PVP Procedure Volume Growth SAN JOSE, Calif., Nov. 3...

Laserscope Schedules 2005 Third Quarter Conference Call

SAN JOSE, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Laserscope (NASDAQ:LSCP), a pioneer in the development and commercialization of...

Laserscope to Present at C.E. Unterberg, Towbin Emerging Growth Life Sciences Conference

SAN JOSE, Calif., Oct. 21 /PRNewswire-FirstCall/ -- Laserscope (NASDAQ:LSCP), a pioneer in the development and commercialization of...

Standard & Poor's Announces Changes to U.S. Indices

NEW YORK, Oct. 4 /PRNewswire/ -- Standard & Poor's will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 indices:...

Not Your Father's Prostate Treatment

? There is encouraging news for the estimated 14 million American men who may experience the pain and embarrassment of an enlarged prostate this...

First Long-Term Study of Photoselective Vaporization of the Prostate (PVP) Reinforces Procedure as an Effective, Long-Term Treat

In Support of Milestone Study Published in the October Issue of the Journal of Urology, Laserscope Launches National 'Heal BPH' Initiative in...

Laserscope's Greenlight PV(R) Laser System Shows Potential for Treating Kidney Tumors

Researchers at the Cleveland Clinic Report Positive Results of Feasibility Trial SAN JOSE, Calif., Sept. 20 /PRNewswire-FirstCall/ -- Laserscope...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Laserscope (MM) (LSCP)

Empower your portfolio: Real-time discussions and actionable trading ideas.

LSCP News

Laserscope Reports 2005 Fourth Quarter and Year-End Operating Results

Laserscope Schedules 2005 Fourth Quarter and Year-End Conference Call

Laserscope Announces Issuance of U.S. Patent

European Study Highlights Laserscope's Greenlight PV(R) System Effective in Relieving BPH Symptoms With Improved Safety and Lowe

Laserscope Provides Details About New CMS Reimbursement for In-Office PVP Procedure

Laserscope Announces Intended Resignation of Board Member

Laserscope to Present at Harris Nesbitt Focus on Healthcare Conference

Laserscope to Present at Lazard Capital Markets Life Sciences Conference

Laserscope Reports 2005 Third Quarter Operating Results, Updates Guidance for 2005 and Sets Initial Guidance for 2006

Laserscope Schedules 2005 Third Quarter Conference Call

Laserscope to Present at C.E. Unterberg, Towbin Emerging Growth Life Sciences Conference

Standard & Poor's Announces Changes to U.S. Indices

Not Your Father's Prostate Treatment

First Long-Term Study of Photoselective Vaporization of the Prostate (PVP) Reinforces Procedure as an Effective, Long-Term Treat

Laserscope's Greenlight PV(R) Laser System Shows Potential for Treating Kidney Tumors

LSCP Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Laserscope (MM) (LSCP) News

Laserscope (MM) (LSCP)

Empower your portfolio: Real-time discussions and actionable trading ideas.

LSCP News

Laserscope Reports 2005 Fourth Quarter and Year-End Operating Results

Laserscope Schedules 2005 Fourth Quarter and Year-End Conference Call

Laserscope Announces Issuance of U.S. Patent

European Study Highlights Laserscope's Greenlight PV(R) System Effective in Relieving BPH Symptoms With Improved Safety and Lowe

Laserscope Provides Details About New CMS Reimbursement for In-Office PVP Procedure

Laserscope Announces Intended Resignation of Board Member

Laserscope to Present at Harris Nesbitt Focus on Healthcare Conference

Laserscope to Present at Lazard Capital Markets Life Sciences Conference

Laserscope Reports 2005 Third Quarter Operating Results, Updates Guidance for 2005 and Sets Initial Guidance for 2006

Laserscope Schedules 2005 Third Quarter Conference Call

Laserscope to Present at C.E. Unterberg, Towbin Emerging Growth Life Sciences Conference

Standard & Poor's Announces Changes to U.S. Indices

Not Your Father's Prostate Treatment

First Long-Term Study of Photoselective Vaporization of the Prostate (PVP) Reinforces Procedure as an Effective, Long-Term Treat

Laserscope's Greenlight PV(R) Laser System Shows Potential for Treating Kidney Tumors

LSCP Discussion

Your Recent History